REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/28/2026
Back to search
Official data from USPTO
IPSEN BIOPHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IPSEN BIOPHARMACEUTICALS
ST13
US500000085519918Class
5
Filing
85519918
Registration
5171734
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
101
Latest update
03/29/2026
Trademark type
Word
Nice classes
5
Filing date
01/19/2012
Registration date
03/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/17/2023
Last transaction
03/29/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/16/2012
First use in commerce
04/16/2012
Drawing code
4
Owner type
99
Owner location
Paris, FR
Examiner
DINALLO, KEVIN M
Law office
L70
Current location
TMEG LAW OFFICE 107
Holders and representatives
Holders
IPSEN S.A.
IPSEN S.A.
Representatives
Ben Natter HAUG PARTNERS, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in oncologyendocrinologyneurologyhematologygastroenterologyfor cardiovascular and cognitive disorders; pharmaceutical preparations for use in urologypharmaceutical preparations for the treatment of glabellar linesfacial wrinklesasymmetries and defects and conditions of the human skin; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders; pharmaceutical preparations for the treatment and prevention of cervical dystoniacerebral palsyspasticity
Publications
History of USPTO decisions and trademark events.
101 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/29/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/29/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/29/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/29/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/29/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/23/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/23/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/23/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/23/2023
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/17/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
08/17/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/17/2023
ES8R
TEAS SECTION 8 RECEIVED
03/16/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/28/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/14/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/14/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/14/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/14/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/14/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/14/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/06/2022
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/06/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/06/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/06/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/06/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/30/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/30/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/30/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/30/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/30/2021
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
06/18/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/15/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/15/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
05/15/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/15/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/15/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/15/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/24/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/23/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
02/23/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/23/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
02/23/2017
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
02/23/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/26/2016
GNFR
FINAL REFUSAL E-MAILED
08/26/2016
CNFR
SU - FINAL REFUSAL - WRITTEN
08/26/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/08/2016
GNRT
NON-FINAL ACTION E-MAILED
01/08/2016
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/08/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/15/2015
IUAF
USE AMENDMENT FILED
12/10/2015
EISU
TEAS STATEMENT OF USE RECEIVED
12/10/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/16/2015
EX5G
SOU EXTENSION 5 GRANTED
06/13/2015
EXT5
SOU EXTENSION 5 FILED
05/28/2015
EEXT
SOU TEAS EXTENSION RECEIVED
05/28/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2014
EX4G
SOU EXTENSION 4 GRANTED
12/01/2014
EXT4
SOU EXTENSION 4 FILED
11/24/2014
EEXT
SOU TEAS EXTENSION RECEIVED
11/24/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/23/2014
EX3G
SOU EXTENSION 3 GRANTED
05/22/2014
EXT3
SOU EXTENSION 3 FILED
05/15/2014
EEXT
SOU TEAS EXTENSION RECEIVED
05/15/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/17/2013
EX2G
SOU EXTENSION 2 GRANTED
12/16/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/07/2013
EXT2
SOU EXTENSION 2 FILED
10/22/2013
EEXT
SOU TEAS EXTENSION RECEIVED
10/22/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/05/2013
EX1G
SOU EXTENSION 1 GRANTED
06/03/2013
EXT1
SOU EXTENSION 1 FILED
06/03/2013
EEXT
SOU TEAS EXTENSION RECEIVED
06/03/2013
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/11/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/16/2012
PUBO
PUBLISHED FOR OPPOSITION
10/16/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/26/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/11/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/10/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
09/10/2012
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/10/2012
GNEA
EXAMINERS AMENDMENT E-MAILED
09/10/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/10/2012
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
09/07/2012
GPRA
PRIORITY ACTION E-MAILED
09/07/2012
CPRA
PRIORITY ACTION WRITTEN
09/07/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2012
ALIE
ASSIGNED TO LIE
08/03/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/01/2012
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
04/27/2012
GPRA
PRIORITY ACTION E-MAILED
04/27/2012
CPRA
PRIORITY ACTION WRITTEN
04/27/2012
DOCK
ASSIGNED TO EXAMINER
04/26/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/24/2012
NWAP
NEW APPLICATION ENTERED
01/23/2012
Continuous trademark protection
Get notified about every new filing that threatens IPSEN BIOPHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.